Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence.

[1]  V. Basevi.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[2]  Desmond E. Williams,et al.  Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988–1994 and 2005–2006 , 2009, Diabetes Care.

[3]  F. Hu,et al.  Fasting and postchallenge hyperglycemia and risk of cardiovascular disease in Chinese: the Chin-Shan Community Cardiovascular Cohort study. , 2008, American heart journal.

[4]  S. Wannamethee,et al.  The metabolic syndrome and cardiovascular risk in the British Regional Heart Study , 2008, International Journal of Obesity.

[5]  J. Murabito,et al.  Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. , 2008, Journal of the American College of Cardiology.

[6]  J. Shaw,et al.  Risk of Cardiovascular and All-Cause Mortality in Individuals With Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) , 2007, Circulation.

[7]  B. Hedblad,et al.  The metabolic syndrome and incidence of cardiovascular disease in non‐diabetic subjects—a population‐based study comparing three different definitions , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[8]  L. Kinnunen,et al.  How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population? , 2007, Atherosclerosis.

[9]  S. Grundy,et al.  Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. , 2007, American heart journal.

[10]  M. Laakso,et al.  The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. , 2007, European heart journal.

[11]  J. Pankow,et al.  Cardiometabolic Risk in Impaired Fasting Glucose and Impaired Glucose Tolerance , 2007, Diabetes Care.

[12]  L. Bouter,et al.  High Risk of Cardiovascular Mortality in Individuals With Impaired Fasting Glucose Is Explained by Conversion to Diabetes , 2007, Diabetes Care.

[13]  C. Murray,et al.  Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment , 2006, The Lancet.

[14]  P. Savage,et al.  Metabolic Syndrome and Cardiovascular Disease in Older People: The Cardiovascular Health Study , 2006, Journal of the American Geriatrics Society.

[15]  R. Sega,et al.  Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[16]  Po Box,et al.  Excess risk of fatal coronary heart disease associated with diabetes in men and women:meta-analysis of 37 prospective cohort studies , 2006 .

[17]  M. Woodward,et al.  Does sex matter in the associations between classic risk factors and fatal coronary heart disease in populations from the Asia-Pacific region? , 2005, Journal of women's health.

[18]  V. Gudnason,et al.  Glucose abnormalities and heart failure predict poor prognosis in the population-based Reykjavik Study , 2005, European Journal of Cardiovascular Prevention & Rehabilitation.

[19]  S. Wild,et al.  Criteria for previously undiagnosed diabetes and risk of mortality: 15‐year follow‐up of the Edinburgh Artery Study cohort , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[20]  Maria Inês Schmidt,et al.  The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. , 2005, Diabetes care.

[21]  G. Meyer-Schwickerath,et al.  Photocoagulation therapy of proliferative retinopathy in young onset Type 1 (insulin-dependent) diabetes , 1982, Diabetologia.

[22]  E. Ford,et al.  Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. , 2004, Archives of internal medicine.

[23]  Ken Williams,et al.  National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study , 2004, Circulation.

[24]  E. Tai,et al.  Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. , 2004, Diabetes care.

[25]  K. Tatara,et al.  Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. , 2004, Diabetes research and clinical practice.

[26]  H. Keen,et al.  The Bedford Survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics , 1982, Diabetologia.

[27]  T. Md.  Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin , 2004, Diabetologia.

[28]  J. Tuomilehto,et al.  Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. , 2003, Diabetes care.

[29]  S. Kiechl,et al.  Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. , 2003, Diabetes care.

[30]  K. Jablonski,et al.  Effects of isolated post-challenge hyperglycemia on mortality in American Indians: the Strong Heart Study. , 2003, Annals of epidemiology.

[31]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[32]  J. Tuomilehto,et al.  Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? , 2003, Diabetes care.

[33]  L. Guize,et al.  Impaired Fasting Glucose, Blood Pressure and Cardiovascular Disease Mortality , 2002, Hypertension.

[34]  E. Barrett-Connor,et al.  Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. , 2002, Archives of internal medicine.

[35]  S. Saydah,et al.  Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. , 2001, Diabetes care.

[36]  C. Loria,et al.  Subclinical states of glucose intolerance and risk of death in the U.S. , 2001, Diabetes care.

[37]  E. Feskens,et al.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. , 2001, Archives of internal medicine.

[38]  B. Zinman,et al.  Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. , 2000, Diabetes care.

[39]  P. Savage,et al.  Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria , 1999, The Lancet.

[40]  L. Bouter,et al.  Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study , 1999, Diabetologia.

[41]  A Sekikawa,et al.  Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. , 1999, Diabetes care.

[42]  M. Laakso,et al.  Hyperglycemia and cardiovascular disease in type 2 diabetes. , 1999, Diabetes.

[43]  S. Yusuf,et al.  The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.

[44]  A. Tobías.  Assessing the influence of a single study in the meta-anyalysis estimate , 1999 .

[45]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[46]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[47]  M. Fujishima,et al.  Diabetes and Cardiovascular Disease in a Prospective Population Survey in Japan: The Hisayama Study , 1996, Diabetes.

[48]  M. Laakso,et al.  Diabetes and atherosclerosis: an epidemiologic view. , 1987, Diabetes/metabolism reviews.

[49]  S Greenland,et al.  Quantitative methods in the review of epidemiologic literature. , 1987, Epidemiologic reviews.

[50]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[51]  P Ducimetière,et al.  Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. , 1985, Hormone and metabolic research. Supplement series.

[52]  R J Jarrett,et al.  Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. , 1983, British medical journal.

[53]  M. Shipley,et al.  CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall Study , 1980, The Lancet.

[54]  I. Pless,et al.  West Indian one-year-olds. A comparative analysis of health and service utilisation. , 1967, Lancet.